BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Conno B, Pesce M, Chiurazzi M, Andreozzi M, Rurgo S, Corpetti C, Seguella L, Del Re A, Palenca I, Esposito G, Sarnelli G. Nutraceuticals and Diet Supplements in Crohn's Disease: A General Overview of the Most Promising Approaches in the Clinic. Foods 2022;11:1044. [PMID: 35407131 DOI: 10.3390/foods11071044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Rastogi S, Singh A. Gut microbiome and human health: Exploring how the probiotic genus Lactobacillus modulate immune responses. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1042189] [Reference Citation Analysis]
2 Núñez-sánchez MA, Melgar S, O’donoghue K, Martínez-sánchez MA, Fernández-ruiz VE, Ferrer-gómez M, Ruiz-alcaraz AJ, Ramos-molina B. Crohn’s Disease, Host–Microbiota Interactions, and Immunonutrition: Dietary Strategies Targeting Gut Microbiome as Novel Therapeutic Approaches. IJMS 2022;23:8361. [DOI: 10.3390/ijms23158361] [Reference Citation Analysis]
3 Aghamohammad S, Sepehr A, Miri ST, Najafi S, Pourshafie MR, Rohani M. The potential role of Bifidobacterium spp. as a preventive and therapeutic agent in controlling inflammation via affecting inflammatory signalling pathways. Lett Appl Microbiol 2022. [PMID: 35876252 DOI: 10.1111/lam.13793] [Reference Citation Analysis]
4 Pesce M, Seguella L, Del Re A, Lu J, Palenca I, Corpetti C, Rurgo S, Sanseverino W, Sarnelli G, Esposito G. Next-Generation Probiotics for Inflammatory Bowel Disease. Int J Mol Sci 2022;23:5466. [PMID: 35628274 DOI: 10.3390/ijms23105466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]